GFID 범부처방역연계 감연병연구개발재단

Search
  • 알림마당
성과공유
  • 홈
  • 알림마당
  • 성과공유

An Introduction of the Active Vaccine Safety Surveillance System in Foreign Countries

구분
방역연계범부처감염병R&D사업
저자명
Na-Young Jeong, Sang-Shin Park, Eun-Sun Lim, Nam-Kyong Choi
학술지명
Journal of Health Informatics and Statistics
발표년월
2019-11-30
작성일
2023-11-22
조회수
72

1. RFP : 백신 이상반응 연구 및 안정성, 유효성 품질평가 기술개발

2. 해당분과 : 3-2-1 과제

3. 과제명 : 국가예방접종 대상 백신의 한국형 능동감시 시스템 구축

4. 연구책임자 : 최남경(이화여자대학교)


[Abstract]

Vaccines require higher safety standards than most other medicinal products because they are given to healthy individuals, including infants, children, and elderly. Despite various activities by national agencies, public concern about vaccine safety often arises. Post-marketing activities for vaccine safety can be broadly classified into passive and active surveillances. Many countries as well as Korea operate passive vaccine safety surveillance systems that report adverse events related to vaccines. However, the active surveillance systems operate only in several countries, such as the United States of America (USA), Europe, Canada and Australia. In the US, Vaccine Safety Datalink (VSD) and Post-Licensure Rapid Immunization Safety Monitoring (PRISM) were developed in 1990 and 2009 respectively for monitoring vaccine actively. In the case of Europe, the Vaccine Adverse Event Surveillance and Communication (VAESCO) consortium was launched in 2008. After the end of VAESCO, the Accelerated Development of VAccine beNefit-risk Collaboration in Europe (ADVANCE) was organized to establish a vaccine benefit-risk monitoring framework in 2013. Canada has been operating a vaccine active monitoring system known as the Canadian Immunization Monitoring Program, ACTive (IMPACT) since 1991. The objective of this review was to describe and compare background, databases, and analysis systems of various vaccine active surveillance systems in the US, Europe, and Canada. We described the examples of studies on the safety of influenza A (H1N1) vaccines carried out in each system. This review could help provide directions for the future development of the ideal active vaccine safety surveillance system in Korea.